Wanlin Liu is a Managing Director focused on China, including both Buyout and Growth opportunities. She is based in Shanghai.
Prior to joining Carlyle, Ms. Liu was a Managing Director at Goldman Sachs Principal Investment Area, where she had been investing in China for 13 years, with wide experiences ranging across several industries, including healthcare, education, logistics, and financial services. While at Goldman Sachs, Ms.Liu was a director of Neusoft Medical, Topknow Industries, Novast Pharma, and Minsheng Education. Prior to that, Ms. Liu worked in the investment banking division at Credit Suisse.